Fingerprint
- 1 Álíkar rannsakendur
Samstarf og helstu rannsóknarsvið síðastliðin fimm ár
Verkefni
- 2 Lokið
-
MGUS screening RCT: Screening for monoclonal gammopathy of undetermined significance: A population-based randomized clinical trial
Kristinsson, S. Y. (PI)
1/02/17 → 31/01/22
Verkefni: Rannsókn
-
MGUS screening RCT: Screening for monoclonal gammopathy of undetermined significance: A population-based randomized clinical trial
Kristinsson, S. Y. (PI)
1/02/17 → 31/01/22
Verkefni: Rannsókn
-
Erratum: Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study (The Journal of rheumatology (2025) 52 11 DOI: 10.3899/jrheum.2025-0029.)
ICEBIO, 1 feb. 2026, Í: The Journal of rheumatology. 53, 2, s. 232 1 s.Rannsóknarafurð: Framlag til fræðitímarits › Athugasemd/rökræður/viðtal
Opinn aðgangur -
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study
ICEBIO, 1 nóv. 2025, Í: The Journal of rheumatology. 52, 11, s. 1098-1106 9 s.Rannsóknarafurð: Framlag til fræðitímarits › Grein › ritrýni
-
Approaching hypercalcemia in monoclonal gammopathy of undetermined significance: insights from the iStopMM screening study
Jónsdóttir, Á. H., Sigurjónsdóttir, H. Á., Thorsteinsdóttir, S., Long, Þ. E., Sverrisdóttir, I. S., Eyþórsson, E. S., Óskarsson, J. Þ., Pálsson, R., Indriðason, Ó. S., Viðarsson, B., Önundarson, P. T., Ólafsson, Í., Þorsteindóttir, I., Agnarsson, B. A., Sigurðardóttir, M., Jónsson, Á., Hultcrantz, M., Durie, B. G. M., Harding, S. & Landgren, O. og 5 aðrir, , 27 feb. 2025, Í: Blood. 145, 9, s. 970-974 5 s.Rannsóknarafurð: Framlag til fræðitímarits › Grein › ritrýni
Opinn aðgangur -
Correction to: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis (Blood Cancer Journal, (2025), 15, 1, (80), 10.1038/s41408-025-01289-7)
Maeng, C. V., Rögnvaldsson, S., Einarsson Long, T., Brieghel, C., Hermansen, E., Niemann, C. U., Grønbæk, K., Kristinsson, S. Y., Thorsteinsdóttir, S. & Þorsteinsdóttir, S., 27 maí 2025, Í: Blood Cancer Journal. 15, 1, s. 105 105.Rannsóknarafurð: Framlag til fræðitímarits › Athugasemd/rökræður/viðtal
Opinn aðgangur -
Deep immune cell profiling in blood and bone marrow of early stage monoclonal gammopathy: an iStopMM and ECRIN-M3 collaborative study
iStopMM and ECRIN-M3 consortia, Rögnvaldsson, S. & Löve, Þ. J., 27 mar. 2025, Í: Blood Cancer Journal. 15, 1, s. 46Rannsóknarafurð: Framlag til fræðitímarits › Bréf › ritrýni
Opinn aðgangur
Fjölmiðlar
-
ASH 2021: In Iceland, the Value of Screening and Early Treatment Comes Into Focus
Kristinsson, S. Y. & Þórsteinsdóttir, S.
28/12/21
1 atriði af Fjölmiðlaumfjöllun
Fjölmiðlar
-
ASH 2021: In Iceland, the Value of Screening and Early Treatment Comes Into Focus
Kristinsson, S. Y. & Þórsteinsdóttir, S.
28/12/21
1 atriði af Fjölmiðlaumfjöllun
Fjölmiðlar
-
With 80,000 Participants, The Largest Study Of Its Kind Is The First To Evaluate The Benefits Of Screening For A Precursor To The Blood Cancer Multiple Myeloma
19/05/21
15 atriði af Fjölmiðlaumfjöllun
Fjölmiðlar
-
Icelandic Study Assessing Benefit of Population-Based Multiple Myeloma Risk Screening, Intervention
19/05/21
1 atriði af Fjölmiðlaumfjöllun
Fjölmiðlar
-
Icelandic Study Assessing Benefit of Population-Based Multiple Myeloma Risk Screening, Intervention
19/05/21
1 atriði af Fjölmiðlaumfjöllun
Fjölmiðlar